PATENT CLAIM ANALYSIS

Application Number: 16275437
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "183000"]

Abstract:
The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.

Claim (Index 4):
A method of treatment of mild pain comprising administering to a patient in need thereof an effective amount of a co-crystal comprising (rac)-tramadol.HCl and celecoxib in a molecular ratio of 1:1, characterized in that it shows a Powder X-Ray Diffraction pattern with peaks [2\u03b8] at 14.1, 16.8, 19.0 and 22.7[\u00b0], with the 2\u03b8 values being obtained using copper radiation (CuK\u03b11 1.54060 \u212b).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 99.0
- Lexical Diversity: 1.18182
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15207694', '14066127', '15231915', '13395021', '14324448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8186496487965949
- 35 USC 102 Novelty (BERT): 0.6246798340490587
- Combined Prediction Score: 0.7992526673218413
- Mean Citation Score: 560.6519380000002
- Max Citation Score: 625.5047599999998
- Similarity Product: 504.8401928866743

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test